当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Vox Sanguinis杂志
Vox Sanguinis
基本信息
期刊名称 Vox Sanguinis
VOX SANG
期刊ISSN 0042-9007
期刊官方网站 https://onlinelibrary.wiley.com/journal/14230410
是否OA No
出版商 Wiley-Blackwell Publishing Ltd
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 1953
年文章数 129
最新影响因子 1.8(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 HEMATOLOGY 血液学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 4.4 0.699 0.839
Medicine
Hematology
57/137 58%
补充信息
自引率 11.1%
H-index 77
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0042-9007%5BISSN%5D
投稿指南
期刊投稿网址 http://mc.manuscriptcentral.com/vox
收稿范围
Vox Sanguinis reports on all issues related to transfusion medicine, ‘vein to vein’ from donor to recipient, and including cellular therapies. Comments, reviews, original articles, short reports and international fora are published, grouped into eight main sections:


1) Donors and Donations

Donor recruitment and retention
Donor selection
Donor health (vigilance, side effects of donation)
Big data analysis and blood donation
2) Blood Component Collection and Production

Blood collection methods and devices (including apheresis)
Blood component preparation and storage
Inventory management
Collection and storage of cells for cell therapies
Quality management and good manufacturing practice
Automation and information technology
Plasma fractionation techniques and plasma derivatives
3) Transfusion-transmitted Disease and its Prevention

Identification and epidemiology of infectious pathogens transmissible by blood
Donor testing for transfusion-transmissible infectious pathogens
Bacterial contamination of blood components
Pathogen inactivation
4) Transfusion Medicine and New Therapies

Transfusion practice, thresholds and audits
Transfusion efficacy assessment, clinical trials
Non-infectious transfusion adverse events
Therapeutic apheresis
5) Haemovigilance

Near misses, adverse events and side effects throughout the transfusion chain 
Monitoring, reporting and analysis of those adverse events and side effects
Activities aiming at increasing the safety of the whole transfusion chain
Standardization of the definition of adverse events and side effects
6) Patient Blood Management

Caring for patients who might need a transfusion
Transfusion indication decision-making process 
Search for the optimal patient outcomes
Study of transfusion alternatives
Autologous blood transfusion
7) Immunohaematology

Red cell, platelet and granulocyte immunohaematology
Blood phenotyping and genotyping
Molecular genetics of blood groups
Alloimmunity of blood
Pre-transfusion testing
Autoimmunity in transfusion medicine
Blood typing reagents and technology
Immunogenetics of blood cells and serum proteins: polymorphisms and function
Complement in immunohaematology
Parentage testing and forensic immunohaematology
8) Cellular Therapies

Cellular therapy (sources; products; processing and storage; donors)
Cell-based therapies
Genetically modified cell therapies
Stem cells (sources, collection, processing, storage, infusion)
Cellular immunotherapy (e.g., CAR-T cells, NK cells, MSC)
Cell-based regenerative medicine
Molecular therapy
In vitro manufacturing of blood components
Vox Sanguinis also publishes the abstracts associated with international and regional congresses of the ISBT. (Abstracts from meetings other than those held by the ISBT are not accepted.)
收录体裁
投稿指南 https://onlinelibrary.wiley.com/page/journal/14230410/homepage/forauthors.html
投稿模板
参考文献格式
编辑信息

Editor-in-Chief

Dana V. Devine
Vice-President, Medical, Scientific and Research Affairs
Canadian Blood Services Centre for Blood Research
2350 Health Sciences Mall
Vancouver, BC V6T 1Z3
dana.devine@blood.ca


Section Editors

Transfusion-Transmitted Disease and its Prevention

Clive Seed
Australian Red Cross Blood Services
Level 1, 69 Walters Drive,
Herdsman, WA 6017, Australia
cseed@arcbs.redcross.org.au


Blood-Component Collection & Production

Rebecca Cardigan
NHS Blood and Transplant,
Long Road, Cambridge CB2 2PT, UK
rebecca.cardigan@nbs.nhs.uk


Transfusion Medicine and New Therapies

Pierre Tiberghien
Professor of Medicine and Immunology, University of Franche-Comté
Senior Advisor, Etablissement Français du Sang
Paris, France
Pierre.TIBERGHIEN@efs.sante.fr


Immunohaematology & Immunogenetics

Jill R. Storry
Div. Hematology & Transfusion Medicine, Lund University
Immunohematology, Clinical Immunology and Transfusion Medicine
Lund, Sweden
jill.storry@med.lu.se


Cellular Therapy

Zbigniew M. Szczepiorkowski
Department of Pathology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756, USA
Zbigniew.M.Szczepiorkowski@hitchcock.org


International Forum Editor

Miguel Lozano
Department of Hemotherapy and Hemostasis, Hospital Clínic
Barcelona, Spain
mlozano@clinic.ub.es


Review Editors

Leo van de Watering
Sanquin Blood Bank, Southwest Region

Research & Education

Plesmanlaan 1a, Leiden 2333 BZ, The Netherlands

l.vandewatering@sanquin.nl


Zbigniew M. Szczepiorkowski
Department of Pathology, Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756, USA
Zbigniew.M.Szczepiorkowski@hitchcock.org


Text Editor

Douglas W. Huestis, 
Tucson, AZ (USA)


ISBT Standing Committee

G Clarke, Chairperson, Edmonton (Canada)
L Fung, Brisbane (Australia)
E. Jansen, Amsterdam (The Netherlands)
D. Teo, Singapore (Singapore)
D. Devine, Editor in Chief, Vancouver (Canada)


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug